TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
ADRX

ADARx Pharmaceuticals, Inc.

Healthcare · Biotechnology

14.00$ -1.4% vs. previous close Closing price · As of: Nov 16, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ADRX
Line item Q1 25 Q2 25 Q1 26 Q2 26
– – +928.8% -65.1%
– +32.4% +38.1% +4.9%
– -14.8% +31.9% +5.1%
– +19.2% +36.9% +4.9%
– – – –
– – – –
– – – –
– – – –

Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?